""If we can pick off the underlying driver for all of these things, we can have a much greater impact on health and welfare and wellbeing than just working on each individual disease as it pops up.""
""Part of the genius of the idea of LOY-002 is that it achieves some of the same goals biologically as caloric restriction without the hardship and the risks of doing that.""
Loyal is creating a daily prescription pill, LOY-002, aimed at extending the healthy lifespan of senior dogs by addressing metabolic dysfunction. This approach targets the root cause of aging-related issues rather than treating individual diseases. The drug mimics the benefits of caloric restriction without the associated hardships. The STAY study, the largest clinical trial in veterinary medicine, has enrolled 1,300 dogs across 72 clinics to evaluate the drug's effectiveness in improving health and wellbeing.
Read at Fortune
Unable to calculate read time
Collection
[
|
...
]